In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Integra LifeSciences sells $350mm of convertible notes

Executive Summary

Integra LifeSciences (regenerative biomaterials and implantable devices) sold a total of $350mm of senior convertible notes. Investors purchased $165mm principle amount of 2.75% notes due 2010 that convert at $66.26 a share and $165mm of 2.375% notes due 2012 that convert at $64.96 per share. Integra's stock was averaging $50.49 at the time of the sale.
Deal Industry
  • Biotechnology
  • Medical Devices
  • Medical Devices
    • Biomaterials
    • Implantable Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Convertible Debt
    • Private Placement

Related Companies